Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 23556259)


Cervical human papillomavirus infection in a sample of Hispanic women living in Puerto Rico: comparison with cervical cytology reports.

Méndez K, Romaguera J, Pérez CM, Soto-Salgado M, Tortolero-Luna G, Palefsky JM, Ortiz AP.

P R Health Sci J. 2013 Mar;32(1):3-7.


Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.

Mu-Mu-Shwe, Harano T, Okada S, Aye-Aye-Win, Khin-Saw-Aye, Hlaing-Myat-Thu, Mo-Mo-Win, Khin-Khin-Oo, Myo-Khin.

Acta Med Okayama. 2014;68(2):79-87.


Prevalence and risk factors for human papillomavirus DNA in cervical cytology.

Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):168-71. doi: 10.1016/j.ejogrb.2011.06.021. Epub 2011 Jul 18.


Human papillomavirus infection in Brazilian women with normal cervical cytology.

Miranda PM, Pitol BC, Moran MS, Silva NN, Felix PM, Lima-Filho JL, Carneiro CM, Silva ID, Carvalho RF, Lima AA, Beçak W, Stocco RC.

Genet Mol Res. 2012 Jun 29;11(2):1752-61. doi: 10.4238/2012.June.29.8.


Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.

Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ.

Int J Cancer. 2000 Jul 15;87(2):221-7.


Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.

ter Meulen J, Eberhardt HC, Luande J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, Kashaija P, Ockert S, Yu X, et al.

Int J Cancer. 1992 Jun 19;51(4):515-21.


Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial.

Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, Desai M, Mather J, Moss S, Roberts C, Kitchener HC; ARTISTIC Study Group.

Br J Cancer. 2008 May 20;98(10):1704-9. doi: 10.1038/sj.bjc.6604324. Epub 2008 Apr 8.


Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.


Human papillomavirus infection in women in Puerto Rico: agreement between physician-collected and self-collected anogenital specimens.

Ortiz AP, Romaguera J, Pérez CM, Otero Y, Soto-Salgado M, Méndez K, Valle Y, Da Costa M, Suarez E, Palefsky J, Tortolero-Luna G.

J Low Genit Tract Dis. 2013 Apr;17(2):210-7. doi: 10.1097/LGT.0b013e318260e312.


Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC.

Gynecol Oncol. 2010 Aug 1;118(2):116-22. doi: 10.1016/j.ygyno.2010.04.013. Epub 2010 May 21.


Acceptability of cervical and anal HPV self-sampling in a sample of Hispanic women in Puerto Rico.

Ortiz AP, Alejandro N, Pérez CM, Otero Y, Soto-Salgado M, Palefsky JM, Tortolero-Luna G, Romaguera J.

P R Health Sci J. 2012 Dec;31(4):205-12.


Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.

Dalstein V, Riethmuller D, Prétet JL, Le Bail Carval K, Sautière JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C.

Int J Cancer. 2003 Sep 1;106(3):396-403.


Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.

Fernandes JV, Meissner Rde V, Carvalho MG, Fernandes TA, Azevedo PR, de Azevedo JW, de Araújo JM.

Mol Med Rep. 2011 Nov-Dec;4(6):1321-6. doi: 10.3892/mmr.2011.579. Epub 2011 Sep 1.


Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.

Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F, Ensani F, Yarandi F, Mousavi-Jarrahi A, Mohagheghi MA, Moradi A.

Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):529-32.


High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.

Musa J, Taiwo B, Achenbach C, Olugbenga S, Berzins B, Sagay AS, Idoko JA, Kanki PJ, Murphy RL.

Arch Gynecol Obstet. 2013 Dec;288(6):1365-70. doi: 10.1007/s00404-013-2885-x. Epub 2013 May 23.


Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.

Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC.

Cytopathology. 2009 Aug;20(4):249-55. doi: 10.1111/j.1365-2303.2008.00611.x. Epub 2008 Oct 24.


Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.

Tiews S, Steinberg W, Schneider W, Hanrath C.

J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.


Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.

Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Carbillet JP, Lassabe C, Arveux P, Seilles E, Mougin C.

Diagn Mol Pathol. 1999 Sep;8(3):157-64.


Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).

Orlando G, Tanzi E, Chatenoud L, Gramegna M, Rizzardini G; VALHIDATE Study Group.

BMC Cancer. 2012 May 30;12:204. doi: 10.1186/1471-2407-12-204.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk